Winst gevend schreef op 15 september 2025 09:41:
.
.
Published 09/12/2025, 04:55 AM
Recent survey indicated approximately 60% of HAE patients will choose Ekterly as their on-demand medication, supporting JMP’s bullish outlook despite potential early launch volatility.
ZESTIG PROCENT GAAT EKTERLY KIEZEN?JMP highlighted that each start form provides patients with two free boxes of Ekterly,
with each box containing two doses,
representing about $31 million in potential revenue.
The firm noted that some patients are already receiving paid access and refills.
Kalvista is changing its fiscal year end from April 30 to December 31,
which will affect upcoming financial reporting.
JMP projects $7.5 million in revenue for the quarter ending September 30
and $26 million for 2025.